About Phathom Pharma (PHAT)
Phathom Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing treatments for gastrointestinal (GI) diseases. Its product candidate, vonoprazan, is an oral small molecule pot... Read more
- USD10.35
- USD10.37
- USD9.88
- USD17.02
- -0.40%
- 1M
- 292.72k
- 679.84k
- 537M
- 6.07
- -11.40%
Stock News
2 hours ago
Dow Jones Futures Rally 500 Points On Weak Jobs Report; Apple Surges On Buyback News
Yahoo
2 hours ago
Shenandoah Telecommunications Reports Mixed Q1 2024 Results Amidst Major Transactions
Yahoo
2 hours ago
Trimble Inc (TRMB) Q1 2024 Earnings: Surpasses Revenue Forecasts with Strategic Growth Initiatives
Yahoo
2 hours ago
April NZ new vehicle sales slow with start of financial year
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
